文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

前列腺癌碳离子放疗两种每日照射方案的生物有效剂量差异

The Estimated Difference in Biologically Effective Dose Between Two-Opposing-Fields-Per-Day and One-Alternating-Field-Per-Day Carbon Ion Radiation Therapy for Prostate Cancer.
PubMed 文献 · Adv Radiat Oncol · 2025-07-21

本研究比较前列腺癌碳离子放疗中每日两对穿野与每日一交替野方案对危及器官生物有效剂量的差异。处方剂量54 Gy(RBE)分12次,随机选取10例患者,用三种方法计算BED。结果显示两对穿野方案对非中心位置危及器官(尤其股骨头、皮肤、骨髓)BED显著更低,而中心位置器官差异微小。

要点

  • 两对穿野方案对股骨头、皮肤、骨髓等非中心OAR的BED显著低于一交替野方案。
  • 股骨头相对平均BED差异最大:LQ模型约17%,mMKM固定RBE约7%,mMKM(rd=0.38 µm, α/β=3 Gy)约9%,均P<.01。
  • 闭孔肌及尿道、膀胱、直肠等中心OAR的BED差异均小于3%。

核心结论

  • 与每日一交替野方案相比,每日两对穿野方案对非中心位置危及器官产生更低的生物有效剂量,但不同BED估算方法间差异显著。

研究设计与样本

  • 研究纳入10例随机选取的前列腺癌患者,处方剂量为54 Gy(RBE)分12次,比较每日两对穿野与每日一交替野方案的BED差异。
  • BED采用线性二次模型、固定临床RBE为2.41的mMKM以及未重新缩放的mMKM(域半径0.28、0.38、0.45 µm,α/β为3、5、10 Gy)计算。
  • 危及器官按标准指南勾画,使用Wilcoxon符号秩检验进行统计,P<.05为显著。

主要发现

  • 每日两对穿野方案对非中心位置OAR(尤其股骨头、皮肤、骨髓)的BED显著更低。
  • 股骨头相对平均BED差异最大:LQ模型(α/β=3 Gy)约17%,mMKM固定临床RBE约7%,mMKM(rd=0.38 µm,α/β=3 Gy)约9%,所有P值<.01。
  • 闭孔肌及尿道、膀胱、直肠等中心位置OAR的BED差异极小,相对差异均低于3%。

关键数值与推荐

  • 处方剂量:54 Gy(RBE)分12次。
  • BED计算方法:线性二次模型、mMKM固定临床RBE 2.41、mMKM未重新缩放(rd=0.28、0.38、0.45 µm;α/β=3、5、10 Gy)。
  • 股骨头相对平均BED差异:LQ模型(α/β=3 Gy)约17%,mMKM固定RBE约7%,mMKM(rd=0.38 µm,α/β=3 Gy)约9%,均P<.01。
  • 中心位置OAR(闭孔肌、尿道、膀胱、直肠)相对BED差异<3%。

临床怎么用

  • 前列腺癌碳离子放疗中,选择每日两对穿野方案可能降低股骨头、皮肤、骨髓等非中心OAR的BED。
  • BED估算方法的选择会影响非中心OAR剂量比较结果,临床评估需注意方法差异。
  • 该BED降低的临床意义及对毒性的影响尚需进一步研究。

局限性

  • 仅纳入10例患者,样本量小。
  • BED降低的临床意义和对毒性的影响未评估,需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study aims to determine whether two-opposing-fields-per-day (2-fields-per-day) carbon ion radiation therapy for prostate cancer provides a significant advantage in terms of biologically effective dose (BED) for normal tissue compared to the one-alternating-field-per-day (1-field-per-day) approach. METHODS AND MATERIALS: The prescribed dose for carbon ion radiation therapy is 54 Gy (relative biological effectiveness [RBE]) in 12 fractions, and 10 patients were randomly selected for analysis. BED was calculated using 3 methods: the linear-quadratic model, modified microdosimetric kinetic model (mMKM) with a fixed clinical RBE of 2.41 (adopted in most treatment planning systems), and the mMKM without rescaling, using domain radius ( r d ) values of 0.28, 0.38, and 0.45 µm with α / β ratios of 3, 5, and 10 Gy. Organs at risk (OARs) were contoured following standard guidelines. The dosimetric and dose-volume histogram differences, based on BEDs estimated using various methods, were compared between the 2-fields-per-day and 1-field-per-day approaches. Statistical analyses were performed using the Wilcoxon signed rank test with P < .05 considered statistically significant. RESULTS: The 2-fields-per-day approach resulted in significantly lower BED for noncentrally located OARs, particularly the femoral head, skin, and bone marrow. Among these, the femoral head showed the largest relative mean BED difference, with approximately 17% using the linear-quadratic model ( α / β = 3 Gy), 7% with the mMKM model using a fixed clinical RBE, and 9% with the mMKM model ( r d = 0.38 µm, α / β = 3 Gy), with all P values <.01. In contrast, the differences observed for the obturator muscles and other centrally located OARs, including the urethra, bladder, and rectum, were minimal, with relative BED differences remaining below 3%. CONCLUSIONS: Compared to the 1-field-per-day approach, the 2-fields-per-day approach results in lower BED for noncentrally located OARs, though significant variation is observed between the different methods used to estimate BED. The reduction in BED requires further investigation to evaluate its clinical significance and impact on toxicity.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Chiou CC, Liu YM, Lan KL, et al. The Estimated Difference in Biologically Effective Dose Between Two-Opposing-Fields-Per-Day and One-Alternating-Field-Per-Day Carbon Ion Radiation Therapy for Prostate Cancer. Adv Radiat Oncol. 2025. PMID: 41081003. doi:10.1016/j.adro.2025.101863

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。